Disclaimer

The ideas expressed in this blog should not be construed as an enticement to buy or sell the securities, commodities or assets mentioned. The accuracy or completeness of the information provided cannot be guaranteed. Readers should carry out independent verification of information provided. No warranty whatsoever is given and no liability whatsoever is accepted for any loss howsoever arising whether directly or indirectly as a result of actions taken based on ideas and information found in this blog.

Wednesday, December 31, 2025

The Value Fund Portfolio Report for FY2025

1. This is the 2025 full year report for the Value Fund. As the fund size grows, i feel there is a need to be reflective and strategic with my investments. Risk management has become an equal priority to investment returns with increasing size of portfolio and my age.

To set a high bar, I deliberately do not include Property, Options, CPF, SSB, T-Bills and Unit Trust/Mutual Funds as investments into this Value Fund. Consequently, those returns are not counted but can get added as captial injections. However, I do include my SRS portfolio as that is SG equities.

2. The Value Fund had a very good performance compared to 2024. For 2025, TWR & XIRR was 26.2% & 26.5% respectively. Compared to the previous year where my investment strategy muted my returns, this year my investment returns exploded. Better late than never I suppose.  My strategic moves into JP Banks+Trading Houses, CN/HK Tech+Bank, SG Bank+Reit markets  and US AI Tech paid off handsomely all at once. I was one year too early. :@)

Please note that my returns are in SGD as a base currency. I regard this a a higher benchmark compared to those USD based.

3. The Value Fund performed well against all the three benchmark indexes of  ES3(+28.1%), SPY(+11.6%%) and VT(+15.7%). Ironically, I still failed in my long term goal to exceed ES3 by at least 5ppt significantly. SG bluechips dominate the ES3 with their market capitalisation and surged in price with MAS/SGX finally waking up, edging me out by 2 ppt. Sigh, just can't win.

4. The fund's absolute gain again hit a new all-time high at +$983.6K consisting of a realised gain of +$236.0K and unrealised gain of +747.6K. Major contributors to the realised gain were MUFJ, SMFG, MITSUI, TENCENT, ALIBABA. GOOGL, AMZN, DBS and OCBC. The prior years of investments into dividend/income shares also started to pay off with annual dividends also hitting a new high at +$153.1K. Growing dividends has become an upward slope due to the increase valuations across all markets which means it is getting hard to buy anything with both growth and dividends.

5. However, there are Losses and Misses too. Major losers include NVO and TENB while I missed out on the Gold and EU Defense surges. Thankfully, I broke even on my INTC investment and exited with my skin.

6. In terms of capital injection, I added  to the portfolio with my dividends, option premiums, salary bonus, and leverage from wealth lending. Total capital injection into portfolio was +$1,271K for the year. This will not be repeated as I reached the maximum deployment level of my investment capital funds already. 

For those wondering if I use leverage, the answer is yes, a little bit. However, this is LTV against my unit trust/mutal funds which are not included into this Value Fund. So there is no distortion in total portfolio value. At most, I get wiped out in the unit trust/mutal funds and there will be no impact but I seriously doubt that will happen as those are in diversified income funds. It would take a 10 standard deviation event to materialise that.

7. For 2025, Total Stock Portfolio reached $5.18M for the reasons described above. 

8. Against my 2024 Financial Goals Scoreboard, my results are :

    a. Grow my Stock Portfolio Value to $3.5M. (Exceed Target - $5.18M)

    b. Raise dividends to $170K per annum. (Below Target - Only $153.1K)

    c. Exceed or Maintain CAGR of 10%. (Exceed Target - 26.2%)

    d. Top-up CPF Medisave on 1 Jan 2025. (Meet Target)

  e. Review and Refine Options & Risk Strategy to raise returns to SGD4K p.m. (Below Target - Not Enough Time !)

9. For 2026, I need a new investment strategy as everything panned out all at once and contributed to this superlative performance. The risks are also rising on all fronts at once. I need to circle the wagons around my portfolio but need ideas for upside gains to maintain a long term 10% CAGR. This is work in progress.

Going forward into 2026, my (stretch) investment goals are:

a. Grow my Stock Portfolio Value to $6M.

b. Raise dividends to $200K p.a. 

c. Exceed or Maintain CAGR of 10%. 

d. Top-up CPF Medisave on 1 Jan 2026.

e. Review and Refine Options & Risk Strategy to raise returns to SGD3000 per month.


10. My current portfolio can be found at 
https://stocks.cafe/user/profile?username=thevaluefund

No comments:

Post a Comment